Evidence map›Paper›PMID 16238610›Full record

ReviewOrthodontics & craniofacial research2005

Current concepts in periodontal bioengineering.

M Taba, Q Jin, J V Sugai, W V Giannobile

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Orthodontics & craniofacial research, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00755911 (Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy), which is not on this map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00755911 phase1 / phase2completednot on this mapstarted 2008, after this paper: background citation

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

TypeinterventionalSponsorUniversity of MichiganRan2008 to 2012Enrolled24ConditionsAlveolar Bone LossArmsTissue Repair Cells (TRC), Control
3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 242 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Recent advances in GTR scaffolds.Bioinformation · 2022
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

M TabaDepartment of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, 48108, USA.
Q Jin
J V Sugai
W V Giannobile
University of Michigan–Ann Arbor · USAnn Arbor Center for Independent Living · US

Funding

GENE THERAPY FOR RECONSTRUCTING PERIODONTAL TISSUESR01DE013397 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GIANNOBILE, WILLIAM V · 2000 to 2014
$4.0M
Periodontal Engineering Using Biomimetic Nano ScaffoldsR01DE015384 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MA, PETER X · 2003 to 2011
$2.9M
Biomimetic Nano ScaffoldsR21DE014755 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MA, PETER X · 2003 to 2004
$306k
NIDCR NIH HHS R01 DE013397NIDCR NIH HHS R01 DE015384NIDCR NIH HHS R01 DE13397NIDCR NIH HHS R01-DE15384NIDCR NIH HHS R21-DE01475NIDCR NIH HHS R21 DE014755
6 · The paper itself

Abstract

Repair of tooth supporting alveolar bone defects caused by periodontal and peri-implant tissue destruction is a major goal of reconstructive therapy. Oral and craniofacial tissue engineering has been achieved with limited success by the utilization of a variety of approaches such as cell-occlusive barrier membranes, bone substitutes and autogenous block grafting techniques. Signaling molecules such as growth factors have been used to restore lost tooth support because of damage by periodontal disease or trauma. This paper will review emerging periodontal therapies in the areas of materials science, growth factor biology and cell/gene therapy. Several different polymer delivery systems that aid in the targeting of proteins, genes and cells to periodontal and peri-implant defects will be highlighted. Results from preclinical and clinical trials will be reviewed using the topical application of bone morphogenetic proteins (BMP-2 and BMP-7) and platelet-derived growth factor-BB (PDGF) for periodontal and peri-implant regeneration. The paper concludes with recent research on the use of ex vivo and in vivo gene delivery strategies via gene therapy vectors encoding growth promoting and inhibiting molecules (PDGF, BMP, noggin and others) to regenerate periodontal structures including bone, periodontal ligament and cementum.

Indexed as

Biomimetic MaterialsTissue EngineeringAnimalsConnective Tissue CellsEpithelial CellsExtracellular MatrixGenetic TherapyGrowth SubstancesGuided Tissue Regeneration, PeriodontalHumansNeovascularization, PhysiologicPeriodontiumRegenerationGrowth Substances

Identifiers

PMID16238610
PMCPMC2581520
OpenAlexW2098389224

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.